Opportunity Information: Apply for RFA CK 13 001
Apply for RFA CK 13 001
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Identification, Surveillance, and Control of Vector Borne and Zoonotic Infectious Diseases in Uganda" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Dec 10, 2012 and posted on Dec 7, 2012.
- Applicants must submit their applications by Jan 16, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $15,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $3,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility for award is a sole source foreign entity for research activities located in Uganda.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity, titled "Identification, Surveillance, and Control of Vector Borne and Zoonotic Infectious Diseases in Uganda" (Funding Opportunity Number RFA CK 13 001), was issued by the U.S. Centers for Disease Control and Prevention (CDC) under CFDA 93.283, which covers CDC Investigations and Technical Assistance. It was offered as a discretionary cooperative agreement, meaning the CDC expected to be actively involved in the work alongside the recipient rather than simply providing funds with minimal interaction. The overall purpose was to support work in Uganda that investigates and better defines both the environmental and clinical dimensions of selected infectious diseases that spread either through vectors (such as mosquitoes, ticks, or other carriers) or through zoonotic pathways (spillover between animals and humans), with an emphasis on generating practical approaches to surveillance and control.
At its core, the opportunity aimed to strengthen the ability to identify, monitor, and respond to targeted vector-borne and zoonotic disease threats in the Republic of Uganda. The language of the announcement points to a broad, applied public health focus: improving understanding of where these diseases are present, how they are transmitted, what risk factors drive outbreaks, and what interventions can reduce transmission in people and animals. The scope explicitly includes both environmental aspects (for example, vector ecology, habitat, seasonality, animal reservoirs, and exposure settings) and clinical aspects (such as human and animal case recognition, diagnostic characterization, and patterns of illness). The intended outcome is not only improved scientific characterization, but also actionable means to control or reduce disease risk.
Funding was substantial for a single project: the CDC anticipated making one award, with an estimated total funding amount of $15,000,000. The award size range was listed with an award floor of $1,000,000 and an award ceiling of $3,000,000, indicating the expected annual or project-period structure would be within that band per budget period, depending on the final terms in the full announcement. There was no cost sharing or matching requirement, so applicants were not required to contribute non-federal funds to be eligible. Because the funding instrument was a cooperative agreement, the recipient would typically be expected to coordinate closely with CDC on technical direction, reporting, surveillance strategies, and implementation decisions.
Eligibility was highly restricted. While the general "Eligible Applicants" category is described as "Others," the eligibility details clarify that this was a sole source award to a foreign entity for research activities located in Uganda. In practical terms, that indicates the CDC had a specific implementing partner in mind and was not running an open, competitive solicitation for a broad pool of applicants. The work was to be performed in Uganda, reinforcing that this funding was intended to support in-country research and public health capacity related to vector-borne and zoonotic diseases affecting Ugandan populations and animal hosts.
The timeline shows this was a time-limited opportunity that is now archived. It was posted on December 7, 2012, created on December 10, 2012, and had an original and final closing date of January 16, 2013, with an archive date of February 15, 2013. Anyone looking for the full details would have needed to access the "Full Announcement" section referenced in the listing; the provided additional information link is explicitly noted as not active. For technical difficulties accessing the full announcement at the time, the point of contact was the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), reachable by phone at 770-488-2700.
Overall, the opportunity reflects a CDC-supported effort to improve detection, surveillance, and control of high-consequence infectious disease threats at the human-animal-environment interface in Uganda, combining field and clinical investigation with practical control strategies and close collaboration between the awardee and CDC.
FAQs: Identification, Surveillance, and Control of Vector Borne and Zoonotic Infectious Diseases in Uganda (RFA CK 13 001)
What is the title of this grant opportunity?
The opportunity is titled "Identification, Surveillance, and Control of Vector Borne and Zoonotic Infectious Diseases in Uganda."
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is RFA CK 13 001.
Which agency issued this opportunity?
This opportunity was issued by the U.S. Centers for Disease Control and Prevention (CDC).
What CFDA program does this opportunity fall under?
It was issued under CFDA 93.283, which covers CDC Investigations and Technical Assistance.
What type of funding instrument is it?
It was offered as a discretionary cooperative agreement.
What does a "cooperative agreement" mean for how the project would be run?
A cooperative agreement indicates CDC expected to be actively involved in the work alongside the recipient, rather than simply providing funds with minimal interaction. This typically implies close coordination on technical direction, surveillance strategies, implementation decisions, and reporting.
What is the overall purpose of the opportunity?
The purpose was to support work in Uganda that investigates and better defines both environmental and clinical dimensions of selected vector-borne and zoonotic infectious diseases, with an emphasis on generating practical approaches to surveillance and control.
Where was the work intended to take place?
The work was intended to be performed in Uganda.
What kinds of diseases were the focus?
The focus was on infectious diseases that spread through vectors (such as mosquitoes, ticks, or other carriers) and diseases transmitted through zoonotic pathways (spillover between animals and humans).
What does the opportunity mean by "environmental dimensions" of disease?
The scope includes environmental aspects such as vector ecology, habitat, seasonality, animal reservoirs, and exposure settings.
What does the opportunity mean by "clinical dimensions" of disease?
The scope includes clinical aspects such as human and animal case recognition, diagnostic characterization, and patterns of illness.
What public health outcomes was CDC aiming to strengthen in Uganda?
The opportunity aimed to strengthen the ability to identify, monitor, and respond to targeted vector-borne and zoonotic disease threats in the Republic of Uganda.
What kinds of activities were emphasized?
The announcement emphasized applied public health work such as improving understanding of where diseases are present, how they are transmitted, what risk factors drive outbreaks, and what interventions can reduce transmission in people and animals.
Was the goal only scientific research, or also practical control measures?
Both. The intended outcome included improved scientific characterization and actionable approaches to surveillance and control that could reduce disease risk.
How much funding was anticipated in total?
CDC estimated a total funding amount of $15,000,000 for this opportunity.
How many awards did CDC anticipate making?
CDC anticipated making one award.
What were the listed award floor and ceiling?
The listing included an award floor of $1,000,000 and an award ceiling of $3,000,000.
Does the award floor and ceiling represent annual funding or total project funding?
The opportunity notes that the award size range indicates an expected annual or project-period structure within that band per budget period, depending on the final terms in the full announcement.
Was cost sharing or matching required?
No. There was no cost sharing or matching requirement.
Was this an open, competitive opportunity?
No. Eligibility details indicate this was a sole source award to a foreign entity for research activities located in Uganda, meaning CDC was not running an open competitive solicitation for a broad pool of applicants.
Who was eligible to apply?
The general category is described as "Others," but the eligibility details clarify it was a sole source award to a foreign entity for research activities in Uganda.
Is this opportunity still available?
No. It was time-limited and is now archived.
When was the opportunity posted and when did it close?
It was posted on December 7, 2012, created on December 10, 2012, and had an original and final closing date of January 16, 2013.
When was it archived?
The archive date was February 15, 2013.
How could applicants access the full details?
Full details were referenced in the "Full Announcement" section of the listing. The additional information link provided in the listing is explicitly noted as not active.
Who was the contact for technical difficulties accessing the full announcement?
The point of contact for technical difficulties was the CDC Procurement and Grants Office (PGO), Technical Information Management Section (TIMS), reachable by phone at 770-488-2700.
What is the key theme of the work described in the listing?
The opportunity reflects a CDC-supported effort to improve detection, surveillance, and control of high-consequence infectious disease threats at the human-animal-environment interface in Uganda, combining field and clinical investigation with practical control strategies and close collaboration between the awardee and CDC.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Limited Competition Practice Based Research to Improve Self Management Support (PRISMS) (R18)
Previous opportunity: Water Conservation Field Services Program Phoenix Area Office
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CK 13 001
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CK 13 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition Practice Based Research to Improve Self Management Support (PRISMS) (R18) Apply for RFA HS 13 001 Funding Number: RFA HS 13 001 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $500,000 |
| Medicaid Expansion and Reproductive Health Care for Women Apply for RFA DP 13 002 Funding Number: RFA DP 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| Cost Benefit of Incentive based Smoking Cessation for Pregnant Women Apply for RFA DP 13 003 Funding Number: RFA DP 13 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $560,000 |
| Evaluation of Treatments and Services Provided to People with Duchenne Muscular Dystrophy (DMD) Apply for RFA DD 13 002 Funding Number: RFA DD 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $150,000 |
| Expanding Participation of People with Disabilities in USAID Activities and Strengthen the Capacities of Disabled Peoples Organizations (DPOs) Apply for RFA 114 13 000002 Funding Number: RFA 114 13 000002 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $600,000 |
| AHRQ Mentored Clinical Scientist Research Career Development Award (K08) Apply for PA 13 039 Funding Number: PA 13 039 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| NIA Clinical Trial Planning Grant Program (R34) Apply for PAR 13 040 Funding Number: PAR 13 040 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Immune Mechanisms of Virus Control (U19) Apply for RFA AI 12 048 Funding Number: RFA AI 12 048 Agency: National Institutes of Health Category: Health Funding Amount: $1,500,000 |
| Collaborative Activities to Promote Metabolomics Research (Admin Supp) Apply for PA 13 041 Funding Number: PA 13 041 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| USAID/Cambodia Annual Program Statement (APS) for MATERNALCHILD HEALTH, TUBERCULOSIS, HIV/AIDS, AND Malaria Apply for APS 442 13 000001 Funding Number: APS 442 13 000001 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $100,000 |
| Integrated Preclinical/Clinical AIDS Vaccine Development Program (IPCAVD) (U19) Apply for PA 13 042 Funding Number: PA 13 042 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| International Traumatic Brain Injury Research Initiative NIH Cooperative Program for Comparative Effectiveness of Clinical Tools and Therapies (U01) Apply for RFA NS 13 008 Funding Number: RFA NS 13 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of HIV Related Lung Disease (U01) Apply for RFA HL 13 026 Funding Number: RFA HL 13 026 Agency: National Institutes of Health Category: Health Funding Amount: $440,000 |
| Mechanisms of HIV Related Lung Disease Data Coordinating Center (DCC) (U01) Apply for RFA HL 13 028 Funding Number: RFA HL 13 028 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome wide Data (R03) Apply for PAR 13 044 Funding Number: PAR 13 044 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening Surveillance for Japanese Encephalitis in India Apply for RFA GH 13 004 Funding Number: RFA GH 13 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| AHRQ Health Services Research Projects (R01) Apply for PA 13 045 Funding Number: PA 13 045 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $250,000 |
| AHRQ Health Services Research Demonstration and Dissemination Grants (R18) Apply for PA 13 046 Funding Number: PA 13 046 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: $250,000 |
| Detecting etiologies of emerging infectious diseases at the regional level Western Ghat Region of Karnataka and Kerala, India Apply for RFA GH 13 003 Funding Number: RFA GH 13 003 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| NIH Revision Applications for Research Relevant to the Family Smoking Prevention and Tobacco Control Act (P30) Apply for RFA OD 12 007 Funding Number: RFA OD 12 007 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CK 13 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.